Document Detail


Changes in Pharmaceutical Treatment of Diabetes and Family Financial Burdens.
MedLine Citation:
PMID:  22513449     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Recent changes in diabetes treatment guidelines and the introduction of new, more expensive pharmaceuticals appear to increase the financial challenges for nonelderly adults with diabetes. The authors used Medical Expenditure Panel Survey data to examine changes in the prevalence of diabetes and comorbidities, diabetes treatment, financial burdens, and the relationship between high financial burdens and patient characteristics. From 1997-1998 to 2006-2007, the total number of nonelderly adults treated for diabetes nearly doubled, from 5.4 to 10.7 million, and the proportion of diabetes patients using multiple drugs to treat their condition increased significantly. About a fifth of diabetes patients spent 10% or more of their family income on health care, and about one in nine spent 20% or more of their family income on health care. In 2006-2007, diabetes patients who were older, female, in poor health, or lacked insurance were more likely than others to have high burdens.
Authors:
Eric M Sarpong; Didem M Bernard; G Edward Miller
Related Documents :
8922359 - Increased hexosamine availability similarly impairs the action of insulin and igf-1 on ...
22365209 - The association between metabolic parameters and oocyte quality early and late postpart...
11719829 - Effect of increased plasma non-esterified fatty acids (nefas) on arginine-stimulated in...
22701499 - High serum advanced glycation end-products predict coronary artery disease irrespective...
3523119 - Effect of insulin antibodies and their kinetic characteristics on plasma free insulin d...
22870179 - Insulin analogue levemir and development of pancreatic adenocarcinoma: a case report an...
15919129 - Economic burden on families of childhood type 1 diabetes in urban sudan.
2780489 - Effects of posthatch glucose on poults fed and fasted during yolk sac depletion.
17291479 - Delta-aminolevulinate dehydratase (delta-ala-d) activity in diabetes and hypothyroidism.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-17
Journal Detail:
Title:  Medical care research and review : MCRR     Volume:  -     ISSN:  1552-6801     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9506850     Medline TA:  Med Care Res Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospita...
Next Document:  Dual testing with QF-PCR and karyotype analysis for prenatal diagnosis of chromosomal abnormalities....